Effects of short-acting hypnotics on sleep latency in rats placed on grid suspended over water

European Journal of Pharmacology

Volumn 460, Issue 2-3, 2003, Pages 139-144

  Shinomiya, Kazuaki ^a   Shigemoto, Yuki ^a   Okuma, Chihiro ^a   Mio, Mitsunobu ^a   Kamei, Chiaki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Insomnia; Non rapid eye movement (non REM) sleep; Rapid eye movement (REM) sleep; Short acting hypnotic; Sleep latency; Wakefulness

Indexed keywords

BROTIZOLAM; EVAMYL; LORMETAZEPAM; TRIAZOLAM; WATER; ZOPICLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; LATENT PERIOD; MALE; NONHUMAN; NONREM SLEEP; PRIORITY JOURNAL; RAT; REM SLEEP; SAWDUST; SLEEP DISORDER; SURFACE PROPERTY; WAKEFULNESS;

EID: 0037462479     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02915-1     Document Type: Article

References (28)

1. 14C]-brotizolam in the rat, dog, and rhesus monkey. Arzneim.-Forsch. Drug Res. 36:1986;568-574.
2. Beetar J.T., Guilmette T.J., Sparadeo F.R. Sleep and pain complaints in symptomatic traumatic brain injury and neurologic populations. Arch. Phys. Med. Rehabil. 77:1996;1298-1302.
3. Böke-Kuhn K., Danneberg P., Kuhn F.J., Lehr E. Antiemotional and anticonvulsant activity of brotizolam and its effects on motor performance in animals. Arzneim.-Forsch. Drug Res. 36:1986;528-531.
4. Charney D.S., Mihic S.J., Harris R.A. Hypnotics and sedatives. Hardman J.G., Limbird L.E., Gilman A.G. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 10th ed. 2001;399-427 McGraw-Hill, New York.
5. De Groot J. The rat forebrain in stereotaxic coordinates. Verh. K. Ned. Akad. Wet. Natuurkd. 52:1959;1-40.
6. Fratta W., Collu M., Martellotta M.C., Pichiri M., Muntoni F., Gessa G.L. Stress-induced insomnia: opioid-dopamine interactions. Eur. J. Pharmacol. 142:1987;437-440.
7. Gaillot J., Heusse D., Hougton G.W., Aurele J.M., Dreyfus J.F. Pharmacokinetics and metabolism of zopiclone. Pharmacology. 27:1983;76-91.
8. 14C]lormetazepam in dogs, rabbits, rats and rhesus monkeys. Xenobiotica. 10:1980;401-411.
9. Griebel G., Perrault G., Sanger D.J. Limited anxiolytic-like effects of non-benzodiazepine hypnotics in rodents. J. Psychopharmacol. 12:1998;356-365.
10. Halperin J.M., Miller D., Iorio L.C. Sleep-inducing effects of three hypnotics in a new model of insomnia in rats. Pharmacol. Biochem. Behav. 14:1981;811-814.
11. James G.W.L., Piper D.C. A method for evaluating potential hypnotic compounds in rats. J. Pharmacol. Methods. 1:1978;145-154.
12. Kitagawa H., Esumi Y., Kurosawa S., Sekine S., Yokoshima T. Metabolism of 8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo [4,3-a] [1,4] benzodiazepine, triazolam, a new central depressant: I. Absorption, distribution and excretion in rats, dogs and monkeys. Xenobiotica. 9:1979;415-428.
13. Kovalzon V.M., Tsibulsky V.L. REM-sleep deprivation, stress and emotional behavior in rats. Behav. Brain Res. 14:1984;235-245.
14. A receptors in the regulation of sleep: initial sleep responses to peripherally administered modulators and agonists. Sleep. 22:1999;33-42.
15. Lancel M., Faulhaber J., Deisz R.A. Effect of the GABA uptake inhibitor tiagabine on sleep and EEG power spectra in the rats. Br. J. Pharmacol. 123:1998;1471-1477.
16. Michaud J.-C., Muyard J.-P., Capdevielle G., Ferran E., Giordano-Orsini J.-P., Veyrun J., Roncucci R., Mouret J. Mild insomnia induced by environmental perturbations in the rat: a study of this new model and of its possible applications in pharmacological research. Arch. Int. Pharmacodyn. 259:1982;93-105.
17. Morden B., Mitchell G., Dement W. Selective REM sleep deprivation and compensation phenomena in the rat. Brain Res. 5:1967;339-349.
18. Porkka-Heiskanen T., Smith S.E., Taira T., Urban J.H., Levine J.E., Turek F.W., Stenberg D. Noradrenergic activity in rat brain during rapid eye movement sleep deprivation and rebound sleep. Am. J. Physiol. 268:1995;R1456-R1463.
19. 1-antagonists. Biol. Pharm. Bull. 22:1999;1079-1082.
20. Shibata S., Yamashita K., Yamamoto E., Ozaki T., Ueki S. Effects of benzodiazepine and GABA antagonists on anticonflict effects of antianxiety drugs injected into the rat amygdala in a water-lick suppression test. Psychopharmacology. 98:1989;38-44.
21. Suchecki D., Tufik S. Social stability attenuates the stress in the modified multiple platform method for paradoxical sleep deprivation in the rats. Physiol. Behav. 68:2000;309-316.
22. Vogel G.W. A review of REM sleep deprivation. Arch. Gen. Psychiatry. 32:1975;749-761.
23. Waters W.F., Adams S.G. Jr., Binks P., Varnado P. Attention, stress and negative emotion in persistent sleep-onset and sleep-maintenance insomnia. Sleep. 16:1993;128-136.
24. Weber K.H., Kuhn F.J., Böke-kuhn K., Lehr E., Danneberg P.B., Hommer D., Paul S.M., Skolnick P. Pharmacological and neurochemical properties of 1,4-diazepines with two annelated heterocycles (hetrazepines). Eur. J. Pharmacol. 109:1985;19-31.
25. Wheatley D. Use of anti-anxiety drugs in the medically ill. Psychother. Psychosom. 49:1988;63-80.
26. Wheatley D. Prescribing short-acting hypnosedatives. Current recommendations from a safety perspective. Drug Safety. 7:1992;106-115.
27. Witting W., van der Werf D., Mirmiran M. An on-line automated sleep-wake classification system for laboratory animals. J. Neurosci. Methods. 66:1996;109-112.
28. Young R., Urbancic A., Emrey T.A., Hall P.C., Metcalf G. Behavioral effects of several new anxiolytics and putative anxiolytics. Eur. J. Pharmacol. 143:1987;361-371.